The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between UC San Francisco, UC Berkeley, Genentech (a member of the Roche group) and Roche Holding AG geared to transform the fight against brain diseases and disorders of the central nervous system.